Full Press Release Details
Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
August 11, 8:00 am ET
Aug. 11 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA - News), a
vaccine-focused biotech company in China, announced today that it will hold its
2007 Annual Meeting of Shareholders on Thursday, September 4, 2008 at 9:00 a.m.
Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi Road,
Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua.
All shareholders of record as of August 1, 2008 will be eligible to vote and are
Biotech Ltd.'s 2007 Annual Report, notice of annual general meeting and proxy
statement are available on the investors section of the Company's website http://www.sinovac.com
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu
(influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal
Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional
information about Sinovac is available on its website, http://www.sinovac.com
. To be added to our distribution list, please email: info@sinovac.com.
announcement contains forward-looking statements. These statements are made
under the "safe harbor" provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified by words
or phrases such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements. Among other things, the
business outlook and quotations from management in this press release contain
forward-looking statements. Statements that are not historical facts, including
statements about Sinovac's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and uncertainties.
A number of important factors could cause actual results to differ materially
from those contained in any forward-looking statement. Sinovac does not
undertake any obligation to update any forward-looking statement, except as
required under applicable law.
information, please contact:
Tel: +86-10-8289-9871
Fax: +86-10-6296-6910
Tel: +1-646-536-7017
Tel: +1-646-536-7033